Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100XTMG
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥29m2025-01-01 → 2025-12-31StandaloneNet sales
Revenue¥31m2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥63m2023-01-01 → 2023-12-31vStandaloneNet sales (5-year summary)
Revenue¥976m2022-01-01 → 2022-12-31vStandaloneNet sales (5-year summary)
Revenue¥642m2021-01-01 → 2021-12-31vStandaloneNet sales (5-year summary)
Operating income−¥2.0bn2025-01-01 → 2025-12-31StandaloneOperating income
Operating income−¥1.7bn2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income−¥2.1bn2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income−¥1.7bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥1.9bn2023-01-01 → 2023-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥2.1bn2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax−¥1.7bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income−¥2.1bn2025-01-01 → 2025-12-31StandaloneProfit loss
Net income−¥1.7bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥1.9bn2023-01-01 → 2023-12-31vStandaloneNet income loss (5-year summary)
Net income−¥1.1bn2022-01-01 → 2022-12-31vStandaloneNet income loss (5-year summary)
Net income−¥1.6bn2021-01-01 → 2021-12-31vStandaloneNet income loss (5-year summary)
Total assets¥4.6bnat 2025-12-31StandaloneAssets
Total assets¥3.2bnat 2024-12-31StandaloneAssets
Total assets¥2.0bnat 2023-12-31vStandaloneTotal assets (5-year summary)
Total assets¥2.7bnat 2022-12-31vStandaloneTotal assets (5-year summary)
Total assets¥4.3bnat 2021-12-31vStandaloneTotal assets (5-year summary)
Total liabilities¥556mat 2025-12-31StandaloneLiabilities
Total liabilities¥447mat 2024-12-31StandaloneLiabilities
Net assets / equity¥4.0bnat 2025-12-31StandaloneNet assets
Net assets / equity¥2.8bnat 2024-12-31StandaloneNet assets
Net assets / equity¥1.5bnat 2023-12-31vStandaloneNet assets
Net assets / equity¥2.2bnat 2022-12-31vStandaloneNet assets (5-year summary)
Net assets / equity¥3.6bnat 2021-12-31vStandaloneNet assets (5-year summary)
Cash and deposits¥3.7bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥2.4bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥3.4bnat 2025-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31vStandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-12-31vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.2bnat 2021-12-31vStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.9bn2025-01-01 → 2025-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥2.0bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.3bn2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.7bn2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥20m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥942,0002021-01-01 → 2021-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.2bn2025-01-01 → 2025-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.9bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥114m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-802025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-77.172024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-108.922023-01-01 → 2023-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.312022-01-01 → 2022-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31vStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥136.38at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥110.4at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥74.35at 2023-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥124.2at 2022-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥206.86at 2021-12-31vStandaloneNet assets per share (5-year summary)
Equity ratio87.6%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.5%at 2023-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio81.2%at 2022-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31vStandaloneEquity to asset ratio (5-year summary)
Shares issued29,291,600at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued24,961,600at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,717,100at 2023-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31vStandaloneTotal number of issued shares (5-year summary)
Employees38at 2025-12-31StandaloneNumber of employees
Employees35at 2024-12-31StandaloneNumber of employees
Employees34at 2023-12-31vStandaloneNumber of employees
Employees33at 2022-12-31vStandaloneNumber of employees
Employees33at 2021-12-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 834
ItemContextValueUnit
Other net ope cfCurrentYearDuration_NonConsolidatedMember-9921000JPY
Subtotal ope cfPrior1YearDuration_NonConsolidatedMember-2014856000JPY
Subtotal ope cfCurrentYearDuration_NonConsolidatedMember-1935546000JPY
Interest and dividends income received ope cf inv cfPrior1YearDuration_NonConsolidatedMember2049000JPY
Interest and dividends income received ope cf inv cfCurrentYearDuration_NonConsolidatedMember3918000JPY
Interest expenses paid ope cf fin cfPrior1YearDuration_NonConsolidatedMember-4337000JPY
Interest expenses paid ope cf fin cfCurrentYearDuration_NonConsolidatedMember-5204000JPY
Income taxes paid refund ope cfPrior1YearDuration_NonConsolidatedMember-2944000JPY
Income taxes paid refund ope cfCurrentYearDuration_NonConsolidatedMember-4032000JPY
Net cash provided by used in operating activitiesPrior1YearDuration_NonConsolidatedMember-2020088000JPY
Net cash provided by used in operating activitiesCurrentYearDuration_NonConsolidatedMember-1940866000JPY
Payments into time deposits inv cfPrior1YearDuration_NonConsolidatedMember-1000JPY
Payments into time deposits inv cfCurrentYearDuration_NonConsolidatedMember-73000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration_NonConsolidatedMember-3519000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember-3014000JPY
Proceeds from collection of lease and guarantee deposits inv cfPrior1YearDuration_NonConsolidatedMember240000JPY
Proceeds from collection of lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember－JPY
Payments for lease and guarantee deposits inv cfPrior1YearDuration_NonConsolidatedMember-1424000JPY
Payments for lease and guarantee deposits inv cfCurrentYearDuration_NonConsolidatedMember-4496000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-4705000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-7583000JPY
Proceeds from long term loans payable fin cfPrior1YearDuration_NonConsolidatedMember100000000JPY
Proceeds from long term loans payable fin cfCurrentYearDuration_NonConsolidatedMember100000000JPY
Repayment of long term loans payable fin cfPrior1YearDuration_NonConsolidatedMember-94444000JPY
Repayment of long term loans payable fin cfCurrentYearDuration_NonConsolidatedMember-94444000JPY
Repayments of lease obligations fin cfPrior1YearDuration_NonConsolidatedMember-11925000JPY
Repayments of lease obligations fin cfCurrentYearDuration_NonConsolidatedMember-10177000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration_NonConsolidatedMember2890817000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration_NonConsolidatedMember3193862000JPY
Proceeds from issuance of subscription rights to shares fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYearDuration_NonConsolidatedMember32658000JPY
Payments for the issuance of stock acquisition rights fin cfPrior1YearDuration_NonConsolidatedMember-5002000JPY
Payments for the issuance of stock acquisition rights fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Purchase of treasury stock fin cfPrior1YearDuration_NonConsolidatedMember－JPY
Purchase of treasury stock fin cfCurrentYearDuration_NonConsolidatedMember-1000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember2879444000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember3221897000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember23504000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember-9804000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember878155000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember1263642000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1287763000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember2165918000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember2165918000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember3429561000JPY
Directors compensations sgaPrior1YearDuration_NonConsolidatedMember101053000JPY
Directors compensations sgaCurrentYearDuration_NonConsolidatedMember111790000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember212782000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember198520000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember1088997000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass